# Sezzle Inc.: financial statements, quarterly

SEZL · Nasdaq · CIK 1662991 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sezl.md) · [Financials](/companies/sezl/financials.md) · [Filings](/companies/sezl/filings.md) · [Insiders](/companies/sezl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sezl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.2](/filings/0001662991-24-000294.md) | [22.5 d](/filings/0001662991-25-000041.md) | [25.2](/filings/0001662991-25-000085.md) | [30.2](/filings/0001662991-25-000215.md) | [35.6](/filings/0001662991-25-000257.md) | [48.4 d](/filings/0001662991-26-000016.md) | [48.2](/filings/0001662991-26-000065.md) | [52.0](/filings/0001662991-26-000126.md) | [57.5](/filings/0001662991-25-000257.md) | [69.4 d](/filings/0001662991-26-000016.md) | [73.3](/filings/0001662991-26-000065.md) | [84.7](/filings/0001662991-26-000126.md) |
| Selling, general and administrative | $m | [2.2](/filings/0001662991-24-000294.md) | [1.9 d](/filings/0001662991-25-000041.md) | [2.4](/filings/0001662991-24-000143.md) | [2.5](/filings/0001662991-24-000226.md) | [2.4](/filings/0001662991-24-000294.md) | [4.1 d](/filings/0001662991-25-000041.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [5.3](/filings/0001662991-24-000294.md) | [7.7 d](/filings/0001662991-25-000041.md) | [13.8](/filings/0001662991-25-000085.md) | [16.7](/filings/0001662991-25-000215.md) | [20.8](/filings/0001662991-25-000257.md) | [30.9 d](/filings/0001662991-26-000016.md) | [49.9](/filings/0001662991-26-000065.md) | [36.1](/filings/0001662991-26-000126.md) | [35.6](/filings/0001662991-25-000257.md) | [55.2 d](/filings/0001662991-26-000016.md) | [69.0](/filings/0001662991-26-000065.md) | [55.0](/filings/0001662991-26-000126.md) |
| Interest expense | $m | [4.1](/filings/0001662991-23-000156.md) | [4.5 d](/filings/0001662991-24-000052.md) | [4.1](/filings/0001662991-24-000143.md) | [2.9](/filings/0001662991-25-000215.md) | [3.3](/filings/0001662991-25-000257.md) | [3.4 d](/filings/0001662991-26-000016.md) | [2.9](/filings/0001662991-26-000065.md) | [3.5](/filings/0001662991-26-000126.md) | [3.9](/filings/0001662991-25-000257.md) | [3.7 d](/filings/0001662991-26-000016.md) | [3.0](/filings/0001662991-26-000065.md) | [3.3](/filings/0001662991-26-000126.md) |
| Income tax | $m | [0.0](/filings/0001662991-24-000294.md) | [0.6 d](/filings/0001662991-25-000041.md) | [0.4](/filings/0001662991-25-000085.md) | [(16.1)](/filings/0001662991-25-000215.md) | [2.2](/filings/0001662991-25-000257.md) | [2.4 d](/filings/0001662991-26-000016.md) | [10.8](/filings/0001662991-26-000065.md) | [5.1](/filings/0001662991-26-000126.md) | [5.0](/filings/0001662991-25-000257.md) | [8.9 d](/filings/0001662991-26-000016.md) | [14.7](/filings/0001662991-26-000065.md) | [10.9](/filings/0001662991-26-000126.md) |
| Net income | $m | [1.3](/filings/0001662991-24-000294.md) | [2.9 d](/filings/0001662991-25-000041.md) | [8.0](/filings/0001662991-25-000085.md) | [29.7](/filings/0001662991-25-000215.md) | [15.4](/filings/0001662991-25-000257.md) | [25.4 d](/filings/0001662991-26-000016.md) | [36.2](/filings/0001662991-26-000065.md) | [27.6](/filings/0001662991-26-000126.md) | [26.7](/filings/0001662991-25-000257.md) | [42.7 d](/filings/0001662991-26-000016.md) | [51.3](/filings/0001662991-26-000065.md) | [40.8](/filings/0001662991-26-000126.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001662991-24-000294.md) | not reported | [0.22](/filings/0001662991-25-000085.md) | [0.82](/filings/0001662991-25-000215.md) | [0.44](/filings/0001662991-25-000257.md) | not reported | [1.00](/filings/0001662991-26-000065.md) | [0.78](/filings/0001662991-26-000126.md) | [0.75](/filings/0001662991-25-000257.md) | not reported | [1.47](/filings/0001662991-26-000065.md) | [1.17](/filings/0001662991-26-000126.md) |
| Basic EPS | $ per share | [0.23](/filings/0001662991-24-000294.md) | not reported | [0.24](/filings/0001662991-25-000085.md) | [0.87](/filings/0001662991-25-000215.md) | [0.46](/filings/0001662991-25-000257.md) | not reported | [1.07](/filings/0001662991-26-000065.md) | [0.82](/filings/0001662991-26-000126.md) | [0.78](/filings/0001662991-25-000257.md) | not reported | [1.52](/filings/0001662991-26-000065.md) | [1.21](/filings/0001662991-26-000126.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [65.2](/filings/0001662991-23-000156.md) | [67.6](/filings/0001662991-25-000041.md) | [77.8](/filings/0001662991-24-000143.md) | [58.0](/filings/0001662991-24-000226.md) | [80.1](/filings/0001662991-24-000294.md) | [73.2](/filings/0001662991-26-000016.md) | [88.9](/filings/0001662991-25-000085.md) | [88.9](/filings/0001662991-25-000215.md) | [104](/filings/0001662991-25-000257.md) | [64.1](/filings/0001662991-26-000126.md) | [120](/filings/0001662991-26-000065.md) | [79.8](/filings/0001662991-26-000126.md) |
| Current assets | $m | [176](/filings/0001662991-23-000156.md) | [209](/filings/0001662991-25-000041.md) | [192](/filings/0001662991-24-000143.md) | [190](/filings/0001662991-24-000226.md) | [232](/filings/0001662991-24-000294.md) | [258](/filings/0001662991-26-000016.md) | [266](/filings/0001662991-25-000085.md) | [312](/filings/0001662991-25-000215.md) | [329](/filings/0001662991-25-000257.md) | [352](/filings/0001662991-26-000126.md) | [411](/filings/0001662991-26-000065.md) | [408](/filings/0001662991-26-000126.md) |
| Total assets | $m | [180](/filings/0001662991-23-000156.md) | [213](/filings/0001662991-25-000041.md) | [196](/filings/0001662991-24-000143.md) | [212](/filings/0001662991-24-000226.md) | [253](/filings/0001662991-24-000294.md) | [298](/filings/0001662991-26-000016.md) | [298](/filings/0001662991-25-000085.md) | [351](/filings/0001662991-25-000215.md) | [367](/filings/0001662991-25-000257.md) | [400](/filings/0001662991-26-000126.md) | [454](/filings/0001662991-26-000065.md) | [456](/filings/0001662991-26-000126.md) |
| Current liabilities | $m | [83.4](/filings/0001662991-23-000156.md) | [187](/filings/0001662991-25-000041.md) | [92.9](/filings/0001662991-24-000143.md) | [91.9](/filings/0001662991-24-000226.md) | [96.9](/filings/0001662991-24-000294.md) | [106](/filings/0001662991-26-000016.md) | [102](/filings/0001662991-25-000085.md) | [88.9](/filings/0001662991-25-000215.md) | [93.7](/filings/0001662991-25-000257.md) | [89.8](/filings/0001662991-26-000126.md) | [113](/filings/0001662991-26-000065.md) | [102](/filings/0001662991-26-000126.md) |
| Total liabilities | $m | [162](/filings/0001662991-23-000156.md) | [191](/filings/0001662991-25-000041.md) | [166](/filings/0001662991-24-000143.md) | [162](/filings/0001662991-24-000226.md) | [192](/filings/0001662991-24-000294.md) | [211](/filings/0001662991-26-000016.md) | [172](/filings/0001662991-25-000085.md) | [220](/filings/0001662991-25-000215.md) | [212](/filings/0001662991-25-000257.md) | [230](/filings/0001662991-26-000126.md) | [258](/filings/0001662991-26-000065.md) | [223](/filings/0001662991-26-000126.md) |
| Shareholders' equity | $m | [18.0](/filings/0001662991-24-000294.md) | [22.1](/filings/0001662991-26-000016.md) | [29.6](/filings/0001662991-25-000215.md) | [50.3](/filings/0001662991-25-000257.md) | [61.1](/filings/0001662991-25-000257.md) | [87.8](/filings/0001662991-26-000126.md) | [126](/filings/0001662991-26-000126.md) | [130](/filings/0001662991-26-000126.md) | [155](/filings/0001662991-25-000257.md) | [170](/filings/0001662991-26-000126.md) | [197](/filings/0001662991-26-000126.md) | [233](/filings/0001662991-26-000126.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(13.2) d](/filings/0001662991-24-000294.md) | [(15.0) d](/filings/0001662991-25-000041.md) | [16.0](/filings/0001662991-26-000016.md) | [22.2 d](/filings/0001662991-26-000016.md) | [35.1 d](/filings/0001662991-26-000016.md) | [57.4 d](/filings/0001662991-26-000016.md) | [52.5](/filings/0001662991-26-000065.md) | [23.1 d](/filings/0001662991-26-000126.md) | [63.7 d](/filings/0001662991-26-000016.md) | [70.6 d](/filings/0001662991-26-000016.md) | [89.0](/filings/0001662991-26-000065.md) | [52.2 d](/filings/0001662991-26-000126.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001662991-24-000294.md) | [0.0 d](/filings/0001662991-25-000041.md) | [0.0](/filings/0001662991-25-000085.md) | [0.0 d](/filings/0001662991-25-000215.md) | [0.0 d](/filings/0001662991-25-000257.md) | [0.0 d](/filings/0001662991-26-000016.md) | [0.0](/filings/0001662991-26-000065.md) | [0.4 d](/filings/0001662991-26-000126.md) | [0.2 d](/filings/0001662991-25-000257.md) | [0.1 d](/filings/0001662991-26-000016.md) | [0.4](/filings/0001662991-26-000065.md) | [0.4 d](/filings/0001662991-26-000126.md) |
| Share repurchases | $m | [0.3 d](/filings/0001662991-24-000294.md) | [0.0 d](/filings/0001662991-25-000041.md) | [3.8](/filings/0001662991-25-000085.md) | [10.6 d](/filings/0001662991-25-000215.md) | [7.8 d](/filings/0001662991-25-000257.md) | [1.5 d](/filings/0001662991-26-000016.md) | [2.4](/filings/0001662991-26-000065.md) | [28.2 d](/filings/0001662991-26-000126.md) | [4.0 d](/filings/0001662991-25-000257.md) | [30.0 d](/filings/0001662991-26-000016.md) | [25.7](/filings/0001662991-26-000065.md) | [7.1 d](/filings/0001662991-26-000126.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.0](/filings/0001662991-23-000156.md) | [5.6](/filings/0001662991-24-000143.md) | [5.7](/filings/0001662991-24-000226.md) | [5.7](/filings/0001662991-24-000294.md) | [35.8](/filings/0001662991-25-000085.md) | [36.1](/filings/0001662991-25-000215.md) | [35.4](/filings/0001662991-25-000257.md) | [36.2](/filings/0001662991-26-000065.md) | [35.5](/filings/0001662991-26-000126.md) | [35.7](/filings/0001662991-25-000257.md) | [34.9](/filings/0001662991-26-000065.md) | [34.7](/filings/0001662991-26-000126.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,675,014 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001662991-26-000126.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.